The Co-Occurrence Nobody Talks About

Research consistently shows that between 20–50% of people with gambling disorder also meet criteria for alcohol use disorder — and vice versa. This isn't coincidence. Both disorders involve dysfunction of the mesolimbic dopamine system, mediated through opioid receptors. The same neurological vulnerability that makes someone susceptible to gambling disorder also increases their risk for alcohol use disorder.

This means many patients arriving for gambling treatment also have an active or historical alcohol problem — and many patients seeking help for drinking also have gambling patterns they haven't thought to mention. We evaluate and treat both.

Naltrexone for Alcohol Use Disorder

Naltrexone is FDA-approved for alcohol use disorder and has been since 1994. It works by blocking opioid receptors that mediate the rewarding effects of alcohol — reducing the dopamine response to drinking, decreasing cravings, and making alcohol feel less compelling. The Sinclair Method — a specific protocol for using naltrexone — uses the medication selectively before drinking episodes to extinguish the conditioned response over time. We discuss all approaches during evaluation.

Vivitrol (monthly injectable naltrexone) is particularly effective for alcohol use disorder in patients who want to avoid daily medication management.

When Both Conditions Are Present

For patients with co-occurring gambling disorder and alcohol use disorder, naltrexone is often the ideal pharmacological choice — it addresses both conditions through the same mechanism, at the same dose, as part of one treatment plan. This eliminates the fragmentation of seeing separate providers for separate disorders that are neurologically the same disorder expressed differently.

Where opioid use disorder is also present, a modified approach using Suboxone for the opioid component and naltrexone for alcohol and gambling is coordinated carefully by our clinical team.

What Treatment Looks Like

Our approach to alcohol use disorder combines medication (naltrexone or Vivitrol), motivational interviewing, and evidence-based therapy. We do not require abstinence as a prerequisite for beginning treatment — we meet patients where they are. Harm reduction and abstinence-oriented approaches are both available depending on patient goals. Most patients can begin treatment via telehealth within the same week as their evaluation.

Suboxone Treatment at Vantara Health

Suboxone (buprenorphine/naloxone) is the gold-standard pharmacological treatment for opioid use disorder, endorsed by SAMHSA, CDC, NIH, and ASAM. It reduces withdrawal symptoms, eliminates opioid cravings, and blocks the rewarding effects of opioids — making relapse less reinforcing and recovery more sustainable.

We prescribe Suboxone via telehealth. Under current DEA regulations, Suboxone can be initiated without a prior in-person visit. Most patients can receive a prescription within 24–48 hours of their telehealth evaluation, sent directly to their pharmacy. We serve patients throughout New York State.

Why We're Different for OUD Patients

Vantara Health is not a generic MAT clinic. Our clinical focus is reward system disorders — and opioid use disorder is one expression of reward system dysfunction. Many of our OUD patients also struggle with gambling disorder, alcohol use disorder, or both. Rather than referring patients to separate providers for each condition, we treat the full clinical picture under one integrated plan.

This matters because fragmented care — a Suboxone prescriber here, a gambling therapist there, a drinking counselor somewhere else — creates gaps where patients fall through. We close those gaps by design.

Vivitrol as an Alternative

For patients who have completed detoxification and want a non-opioid option, Vivitrol (injectable naltrexone) provides 30-day opioid receptor blockade in a single monthly injection. It is appropriate for patients who are fully opioid-free and want protection against relapse without daily oral medication. We discuss both Suboxone and Vivitrol options during evaluation and recommend based on your specific situation and goals.

Access and Insurance

Suboxone is covered by Medicaid, Medicare, and most commercial insurance plans. New York State has strong insurance parity protections for addiction treatment. For uninsured patients, generic buprenorphine is often available for under $30/month at major pharmacies. We confirm coverage before your first appointment.

What Naltrexone Is — and Isn't

Naltrexone is an opioid antagonist: it occupies opioid receptors in the brain without activating them. It produces no high, causes no sedation, creates no dependency, and has no abuse potential. It is not a sedative, not a substitute medication, and not "trading one addiction for another." It is a receptor blocker — it prevents opioid-mediated reward from occurring.

It has been FDA-approved for opioid use disorder since 1984 and alcohol use disorder since 1994. Its use for gambling disorder is off-label but supported by multiple randomized controlled trials and a 2024 network meta-analysis identifying it as the highest-evidence pharmacological option for gambling disorder currently available.

Who Is a Good Candidate?

Good candidate: Someone with gambling disorder, alcohol use disorder, or opioid use disorder (after detox) who wants to reduce the neurological pull of the addiction. Someone motivated to combine medication with therapy. Someone who can commit to regular clinical follow-up.

Not appropriate: Someone currently taking opioid medications (naltrexone will block their effects and can cause withdrawal). Someone with significant liver disease (a baseline liver function test is required). Someone who is opioid-dependent and has not completed detox (Suboxone should be considered first).

What to Expect in the First 8 Weeks

• Week 1–2: Possible mild nausea, typically resolving on its own. Start low, go slow on dosing if sensitive.
• Week 2–4: Many patients notice reduced gambling urges, reduced alcohol cravings, or both. The change is often described as the compulsion feeling "quieter."
• Week 4–8: Significant clinical response in most patients. Therapy becomes more effective as the neurological drive to gamble or drink is reduced.
• Ongoing: Monthly clinical check-ins, dose adjustment if needed, progress monitoring.

The Conversation We'll Have

During your evaluation, we'll review your medical history, current medications, substance use history, and treatment goals. We'll explain exactly what naltrexone can and cannot do, what alternatives exist, and what a realistic treatment trajectory looks like for your situation. There's no pressure to start medication. The consultation is informational as much as clinical — we want you to make an informed decision.

What's Changing in New York City

New York State Gaming Commission approved three full-scale casino licenses for New York City in December 2025. Resorts World NYC — already operating slots in South Ozone Park, Queens — receives authorization to add full table games in 2026, becoming the closest full casino to midtown Manhattan. Hard Rock Metropolitan Park, to be built adjacent to Citi Field in Queens, is targeting a 2030 grand opening. Bally's Bronx completes the trio.

This represents the most significant expansion of gambling access in New York City's history. Sports betting, already legal and ubiquitous on mobile devices since 2022, created a generation of daily bettors before a single table game opened. The combination of mobile access and physical casino proximity will meaningfully increase the number of New Yorkers developing gambling disorder over the next five years.

The Treatment Gap This Creates

There is currently no clinical infrastructure in New York City designed specifically for gambling disorder treatment. General addiction programs include gambling as a footnote. Therapists offer support groups. The medical tools — naltrexone, Vivitrol — that have been proven effective in clinical trials are almost never offered for gambling.

Vantara Health was built to close this gap before it becomes a crisis. We're based in Queens — the borough receiving two of the three new casino licenses — because that's where the clinical need is greatest and most immediate.

The Responsible Gambling Infrastructure Casinos Are Required to Fund

All three NYC casino licensees are required by the New York State Gaming Commission to fund responsible gambling programs. This includes clinical referral pathways for players who develop gambling disorder. Vantara Health is available to serve as a clinical partner for casino operators — providing branded, professional, HIPAA-compliant treatment access for players who need it.

For casino operators, a credible clinical referral partner is both legally required and strategically valuable. It reduces liability, demonstrates genuine responsible gaming commitment, and helps the broader community trust that the casino's presence is managed responsibly.

For New Yorkers Living Near New Casinos

Proximity to casinos is one of the strongest environmental risk factors for gambling disorder. If a casino is opening in your neighborhood and you're already struggling with gambling — or you're concerned you might — this is the ideal time to talk to a specialist. Early intervention produces significantly better outcomes than waiting until the consequences are severe. Our evaluation is free, our first appointment is available this week, and our treatment is covered by most major insurance.

What Vivitrol Actually Does in the Brain

Gambling triggers the brain's reward system through a specific pathway: win-related stimuli cause endogenous opioids to bind to mu-opioid receptors in the nucleus accumbens, which triggers downstream dopamine release. That dopamine release is the "rush" — and it's what reinforces the behavior and drives continued gambling.

Vivitrol occupies those mu-opioid receptors for the full 30-day injection period. When the receptors are blocked, the win-related dopamine surge doesn't happen. Gambling stops producing its neurological reward. Urges diminish not because of willpower, but because the brain's reinforcement mechanism is pharmacologically interrupted.

Vivitrol vs. Daily Naltrexone — Which Is Right for You?

Vivitrol: One injection monthly. Consistent blood levels throughout the month. No daily pill to remember. Ideal for patients who have struggled with medication adherence, are in a high-risk period (casino nearby, high stress, travel), or simply prefer not to think about a daily medication. Administered in-person at our Queens clinic.

Oral naltrexone: Daily pill, typically 50mg. Generic, often under $30/month. More flexible dosing adjustments. Some patients start with oral to confirm tolerability, then transition to Vivitrol for longer-term maintenance.

Both options are effective. We discuss which makes more sense for your situation during the evaluation.

The Injection Visit

Vivitrol is administered intramuscularly — a single injection into the gluteal muscle. The visit takes approximately 15 minutes. A brief clinical check-in occurs before each injection to assess medication response, side effects, and overall progress. Lab monitoring (liver function) is standard at baseline and periodically thereafter.

Patients must not have used opioid medications for at least 7–10 days before starting Vivitrol, as the medication will precipitate withdrawal in opioid-dependent patients. We confirm this during the evaluation.

Insurance Coverage

Vivitrol is covered by most major insurance plans including Medicaid and Medicare. For alcohol use disorder and opioid use disorder, coverage is typically straightforward as Vivitrol is FDA-approved for both. For gambling disorder, billing is managed through co-occurring diagnoses and behavioral health benefits. Our billing team verifies coverage before your first injection — no financial surprises.

The Clinical Evidence Base

Multiple randomized controlled trials have demonstrated that naltrexone — an opioid receptor antagonist — significantly reduces gambling urges, gambling frequency, and money lost to gambling compared to placebo. A 2024 network meta-analysis synthesizing all available pharmacological evidence for gambling disorder ranked naltrexone and nalmefene as the highest-evidence options in the field.

The mechanism is well understood: gambling activates the brain's reward pathway through opioid receptors. Blocking those receptors with naltrexone interrupts the neurological reinforcement that drives compulsive gambling. This is the same mechanism by which naltrexone has been FDA-approved for alcohol use disorder since 1994 and opioid use disorder since 1984.

Why Most Clinicians Haven't Adopted It

The clinical evidence for naltrexone in gambling disorder has been accumulating for over two decades. The reason most patients with gambling disorder are still receiving worksheets and helpline numbers instead of medication comes down to how addiction treatment is organized: most programs were built around substances, and gambling patients are managed as an afterthought within systems that weren't designed for them.

Vantara Health was built from the ground up with gambling disorder as the primary clinical focus. Naltrexone is our first-line pharmacological tool, not a fallback option.

What Medication Does — and Doesn't Do

Naltrexone addresses the neurobiological substrate of the addiction. It reduces the intensity of gambling urges, makes winning feel less rewarding, and creates a physiological window in which behavioral change becomes achievable. It does not eliminate the underlying psychological patterns, financial consequences, or relationship damage — those require therapy and structured support.

For most patients, the combination of medication and CBT produces significantly better outcomes than either alone. The medication quiets the neurological compulsion; the therapy addresses the cognition, the triggers, and the habits that formed around the gambling.

What to Expect When Starting Naltrexone

Following a clinical evaluation and standard pre-treatment screening (liver function test, medication history), most patients can receive a naltrexone prescription sent to their pharmacy within 24–48 hours via telehealth. The most common side effect is mild, temporary nausea in the first 1–2 weeks. Most patients notice a meaningful reduction in gambling urges within 4–6 weeks. Dosing is typically 50mg daily, though some patients benefit from adjustment.

Gambling Disorder Is One Condition with Many Expressions

The DSM-5 classifies gambling disorder as a behavioral addiction — a dysfunction of the brain's opioid-mediated reward pathway. This mechanism doesn't change based on what someone is gambling on. Casino slots, sports parlays, online poker hands, options contracts, and prediction market positions all activate the same neurological reward loop. The specific form of gambling is less clinically relevant than most people assume.

What matters is the pattern: preoccupation, tolerance, loss of control, chasing losses, continued gambling despite consequences. These criteria apply equally whether someone is sitting at a blackjack table, placing a futures bet on their phone, or trading 0DTE options on a Tuesday morning.

Casino Gambling

Traditional casino gambling — slots, table games, poker, roulette — involves direct environmental cues that are powerful relapse triggers: the sounds, the atmosphere, the proximity to cash. With three casinos opening in New York City between 2026 and 2030, this is increasingly a local concern. The near-miss design built into slot machines is particularly effective at sustaining compulsive play — each near-miss activates nearly the same dopamine response as a win.

For patients who gamble at casinos, treatment includes both pharmacological intervention (naltrexone to blunt the reward response) and CBT focused on cue exposure and environmental management strategies.

Sports Betting and Prediction Markets

Mobile sports betting became legal in New York in January 2022 and within months the state became the largest sports betting market in the US by handle. The 24/7 availability, in-play betting, and continuous odds updates create a stimulation loop that is qualitatively different from pre-mobile sports wagering.

Prediction markets — platforms where users bet on the outcomes of political, economic, or current events — are a newer and rapidly growing category. Platforms like Kalshi and Polymarket have introduced a new population of educated, financially sophisticated users to the dopamine loop of event-driven speculation. Clinically, prediction market addiction presents identically to sports betting addiction: escalating position sizes, constant checking, impaired work performance, and significant financial losses rationalized as "research."

Options Trading and Financial Speculation

Options trading — particularly short-dated contracts (0DTE and weekly expiries) — has become one of the most clinically significant but least discussed forms of gambling disorder. The characteristics are identical: variable ratio reinforcement from unpredictable wins, the ability to "chase" losses by doubling position size, 24/5 market access, and a cultural narrative of sophistication that makes the behavior harder to recognize as a problem.

Many patients with options trading addiction do not present to addiction services at all — they present to financial advisors, therapists treating "stress," or not at all until a significant financial crisis forces the issue. Vantara Health treats financial speculation addiction as a clinical subspecialty within gambling disorder. The stigma is lower, the mechanism is identical, and the treatment is the same.

Online Gambling

Online casino platforms, poker rooms, and offshore sportsbooks operate 24 hours a day with no closing time. The privacy of online gambling allows the disorder to progress significantly further before anyone notices — spouses, employers, and family members often have no idea until financial consequences become impossible to hide.

Online gambling disorder also co-occurs frequently with depression, anxiety, and ADHD. The stimulation of online gambling can function as self-medication for underlying conditions — which is why our clinical evaluation assesses for and treats co-occurring conditions as part of the same plan.

The Treatment Approach

Regardless of the form of gambling, the treatment approach at Vantara Health follows the same evidence-based framework:

• Naltrexone or Vivitrol — blocks the opioid receptors mediating the dopamine reward, reducing the neurological pull toward gambling across all its forms
• Cognitive Behavioral Therapy — addresses the specific thought distortions, triggers, and behavioral patterns of each patient's gambling expression
• Underlying condition assessment — evaluates and treats ADHD, anxiety, depression, and other conditions that frequently drive compulsive behavior
• Structured clinical monitoring — regular medication management and progress tracking over time

First consultation is free. Same-week availability. Most insurance accepted.

Why CBT Works for Gambling Disorder

Gambling disorder is not just a neurological problem — it's also a learned behavioral pattern built over months or years. Specific thoughts, emotions, and situations become reliably linked to gambling urges. Certain sports events trigger betting impulses. Financial stress triggers casino visits. Boredom triggers app-opening. Wins trigger more gambling. Losses trigger chasing.

CBT works by systematically identifying and restructuring these patterns. It doesn't rely on willpower. It builds specific skills: recognizing triggers before they lead to gambling, challenging the thoughts that sustain gambling behavior, and developing alternative responses to the emotional states that gambling has been used to manage.

The Cognitive Component — Thought Distortions

Gambling disorder is maintained by a specific set of cognitive distortions that CBT directly targets:

• The gambler's fallacy: believing that past outcomes influence future ones ("I'm due for a win")
• Illusion of control: believing that skill, strategy, or ritual influences genuinely random outcomes
• Selective recall: remembering wins vividly and minimizing or forgetting losses
• Chasing logic: believing that continuing to gamble is the rational response to losses
• Superstitious thinking: attributing wins to personal traits ("I'm good at this") and losses to external factors

Each of these distortions is identifiable, addressable, and responsive to structured cognitive work. Most patients are surprised to recognize how pervasive these patterns are once they're named.

The Behavioral Component — Triggers and Responses

The behavioral component of CBT for gambling disorder involves mapping the specific chain of events that leads to gambling episodes — the triggers, the thoughts, the urges, and the behavior — and systematically interrupting that chain at multiple points.

This includes practical strategies: removing access to gambling apps, implementing financial safeguards, developing a cue exposure hierarchy, and building alternative activities that provide stimulation or relief without gambling. For patients with sports betting or online gambling disorder, this often includes structured digital environment management.

CBT at Vantara Health

CBT at Vantara Health is delivered by clinicians with specific training in gambling disorder — not general therapists applying a generic protocol. Our CBT work is structured, time-limited, and focused on gambling-specific content rather than broad psychotherapy.

For most patients, CBT is most effective when combined with naltrexone or Vivitrol. The medication reduces the neurological intensity of urges, creating a window in which the behavioral skills of CBT become genuinely actionable. Many patients describe the combination as "the medication makes it possible to actually use the skills."

CBT is also an essential component of treatment for co-occurring conditions — depression, anxiety, and ADHD all have strong CBT evidence bases, and the same therapeutic relationship can address multiple conditions simultaneously.

What Sessions Look Like

CBT for gambling disorder is typically delivered in structured 50-minute sessions, weekly or biweekly, over 8–16 weeks. Sessions are available via telehealth (secure video) or in-person at our Queens clinic. Each session has a specific focus — thought records, behavioral experiments, relapse prevention planning — with between-session work to consolidate gains.

Progress is tracked using validated instruments (SOGS, PG-CGI) at regular intervals. Most patients notice meaningful changes in urge frequency and intensity within the first 4–6 sessions.

Why Underlying Conditions Matter So Much

Compulsive behaviors — including gambling disorder — frequently function as regulation strategies for unmanaged internal states. The gambling isn't the primary problem. It's the solution someone found for a problem that was there first.

ADHD produces a chronically understimulated brain that gambling's variable reward schedule temporarily corrects. Anxiety produces rumination and hyperarousal that the focused attention of gambling temporarily quiets. Depression produces anhedonia — an inability to experience normal pleasure — that the artificial dopamine spike of gambling temporarily relieves. Trauma produces emotional numbness that the intensity of gambling temporarily penetrates.

When you treat only the gambling — without addressing what the gambling was doing for the person — you are removing a coping mechanism without replacing it. The relapse rate is high. When you treat the underlying condition alongside the gambling, you remove both the behavior and the driver. Outcomes are significantly better.

ADHD

ADHD is one of the most common and most underdiagnosed co-occurring conditions in gambling disorder. The overlap makes biological sense: ADHD involves dopamine dysregulation in prefrontal circuits — the same circuits implicated in impulse control and reward processing. Gambling's variable, unpredictable reward schedule is uniquely stimulating for the ADHD brain.

Many adults with undiagnosed ADHD have been managing it for years through high-stimulation activities — including gambling. Properly treating the ADHD — with stimulant medication, non-stimulant options, or structured behavioral interventions — often produces a marked reduction in gambling urges. The brain no longer needs to seek stimulation through gambling when the underlying regulatory deficit is addressed.

Anxiety and Depression

Anxiety and depression co-occur with gambling disorder at rates between 30–60%. The directionality is complex: gambling can cause anxiety (from financial stress, secrecy, consequences) and depression (from losses, shame, isolation), but anxiety and depression also predate and drive gambling.

Anxiety-driven gambling often presents as escape gambling — the patient is not seeking excitement but relief. The focused, immersive quality of gambling quiets the anxious mind temporarily. Depression-driven gambling is often about seeking stimulation and connection in a state of profound anhedonia.

Treating the anxiety or depression — with medication, therapy, or both — removes the driver. Patients frequently report that when their anxiety or depression improves, the pull toward gambling diminishes alongside it.

OCD Traits and Trauma

Some gambling disorder presentations have obsessive-compulsive features — the patient is not primarily seeking reward but is trapped in a compulsion they cannot stop despite wanting to. These presentations respond differently to treatment and often require specific attention to the OCD mechanisms (exposure with response prevention, not just CBT or medication).

Trauma — particularly childhood trauma and PTSD — is significantly overrepresented in gambling disorder populations. Gambling can function as a dissociative mechanism, a form of emotional numbing, or a way to feel "in control" of outcomes in an environment where the person felt historically powerless. Trauma-informed care is essential for these patients and standard addiction treatment often misses it entirely.

Sleep Disorders and Social Isolation

Sleep disorders — particularly insomnia — are strongly associated with gambling disorder. The connection is bidirectional: gambling causes sleep disruption (late-night sessions, financial anxiety), and poor sleep worsens impulse control and emotional regulation, increasing vulnerability to gambling. Treating the sleep disorder is often a meaningful intervention on its own.

Social isolation is one of the most underappreciated drivers of compulsive behavior. Gambling — particularly online gambling — provides stimulation, routine, and a form of engagement that substitutes for human connection. Patients who are lonely, socially disconnected, or in life transitions (retirement, job loss, relocation) are at particularly high risk. Treatment that addresses isolation — through community, group therapy, or structured social engagement — produces meaningfully better outcomes than individual clinical care alone.

Our Approach to Underlying Conditions

Vantara Health conducts a comprehensive evaluation at intake that screens for ADHD, anxiety, depression, OCD traits, trauma history, sleep quality, and social functioning. We do not treat gambling in isolation. We treat the person.

Where co-occurring conditions are identified, we treat them as part of the same clinical plan — not as separate referrals to separate providers. This integration is one of the most important things that distinguishes specialized care from generic addiction treatment. A patient whose ADHD, anxiety, and gambling disorder are all treated by the same clinician who understands how they interact will have significantly better outcomes than one whose care is fragmented across three different providers.

• ADHD: Stimulant or non-stimulant medication; behavioral structure
• Anxiety: CBT; SSRI/SNRI if indicated; relaxation and regulation skills
• Depression: Antidepressant medication; behavioral activation; therapy
• Trauma: Trauma-informed CBT; EMDR referral if appropriate
• Sleep: Sleep hygiene; CBT-I (CBT for insomnia); medication if indicated
• Isolation: Group therapy; community connection; structured social engagement

People Taking Ozempic Keep Reporting Something Unexpected

Online forums, patient surveys, and now clinical trials all tell the same story. People who started semaglutide for weight loss or diabetes started noticing that their relationship with alcohol changed. The urge to drink at the end of the day just wasn’t there anymore. Patients who had been gambling for years found themselves walking past a casino and feeling nothing. The compulsion — that pull that had been part of their life for so long — had quietly disappeared.

This wasn’t the drug’s intended effect. But it was consistent enough across enough people that researchers started studying it. What they found was significant.

What the Studies Actually Found

This isn’t a few anecdotes. The studies are large, the results are consistent, and the medical community is paying close attention.

A 2025 clinical trial published in JAMA Psychiatry — one of the most respected journals in medicine — found that people with alcohol use disorder who took low-dose semaglutide for nine weeks drank significantly less and reported substantially lower cravings than those who took a placebo.

A 2024 study in Nature Communications analyzed over 680,000 people and found those taking semaglutide had a 50–56% lower risk of developing or relapsing into alcohol use disorder compared to people on other medications. That’s a massive effect for any treatment, let alone a drug that wasn’t even designed for this purpose.

A separate 2025 study of 228,000 people found GLP-1 medications were associated with a 28–36% reduction in alcohol-related hospitalizations. And a real-world analysis of over 1.3 million patients found patients on GLP-1s had significantly lower rates of opioid overdose and alcohol intoxication.

The evidence is consistent across multiple studies, multiple countries, and millions of patients. Something real is happening.

Why It Works — in Plain Language

GLP-1 medications were designed to reduce appetite by acting on the brain’s reward system. The brain region that tells you “I want more food” is the same region that drives alcohol cravings, gambling urges, and drug-seeking. When GLP-1 medications quiet down that part of the brain, it doesn’t just reduce hunger — it reduces wanting in general.

Patients describe it as the noise going quiet. The mental chatter about when they’ll get to drink, when they can place a bet, how they’ll get their next fix — it becomes less loud. Less urgent. For many people, that mental quiet is something they haven’t experienced in years.

This is a different mechanism from naltrexone, which works by blocking the reward signal when you actually drink or gamble. GLP-1 medications reduce the urge before you even get there. For some patients, using both together may be more effective than either alone.

Can You Get It at Vantara Health?

Possibly, yes — and here’s how it actually works.

GLP-1 medications are FDA-approved for type 2 diabetes and for weight loss in people who are overweight or obese. They are not currently FDA-approved specifically for addiction treatment. However, prescribing a medication for a condition beyond its FDA approval is legal and extremely common in medicine — it’s called off-label prescribing, and it’s how naltrexone for gambling disorder works too.

At Vantara Health, we evaluate whether GLP-1 therapy is appropriate as part of your full clinical picture. If you also have type 2 diabetes, or if you’re overweight or obese, you may already qualify for a GLP-1 prescription — and the addiction benefits would come alongside. If you don’t meet those criteria, we’ll be honest with you about what’s available and why.

The first step is a free 30-minute consultation. We’ll review your full situation, discuss which medications make sense for you, and be straightforward about what the evidence supports.

Who This Is Most Relevant For

• People with gambling disorder or alcohol use disorder who are also overweight, obese, or have type 2 diabetes
• People who have tried naltrexone and want to explore what else is available
• People who have been on Ozempic or Wegovy and noticed changes in their drinking or gambling — and want to understand what happened
• People curious about what the newest options in addiction medicine look like

Why Gambling Disorder Is Different From Every Other Workplace Health Issue

Alcohol and drug use disorders leave visible signs. Gambling disorder leaves none. No smell, no physical impairment, no positive drug test. An employee can be actively gambling thousands of dollars a week — depleting savings, borrowing from family, opening secret credit accounts — and appear completely functional until the moment they don’t. By that point, the crisis is typically severe: a theft investigation, a financial collapse, or an abrupt departure that costs 50–200% of their annual salary to replace.

The invisibility is not accidental. Gambling disorder is specifically characterized by concealment. Employees hide it from spouses, from family, and certainly from employers. Standard EAP referrals produce poor outcomes because most EAPs have no clinical expertise in gambling disorder and employees know it. Generic addiction programs weren’t built for this presentation.

Vantara Health was.

Four Ways We Partner With Organizations

Why Clinical Quality Matters for Your Program

Most EAP programs satisfy the gambling disorder requirement with a hotline number. This produces poor outcomes — both for the employee and for the employer’s investment in the benefit. The clinical difference between a specialized program and a generic referral is significant.

Vantara Health treats gambling disorder with medication-assisted treatment (naltrexone reduces gambling urges by ~40% vs. placebo in clinical trials), comprehensive underlying condition assessment (ADHD, anxiety, depression, and trauma frequently drive gambling behavior and are missed by generic programs), and telehealth-first delivery that removes every practical barrier to employees actually using the benefit.

Employers who implement structured gambling disorder programs typically see reduced absenteeism within 60–90 days of treatment initiation, elimination of the financial misconduct behaviors that escalate to conduct issues, and improved retention among employees who would otherwise leave or be terminated.